Serotonin Agents
Research News and Information

Saturday, November 21, 2009

Emerging drugs for chronic constipation.

30 Aug 2009 Chronic constipation (CC) is one of the most common functional gastrointestinal disorders. CC is estimated to affect up to 27% of the North American population. Although not life-threatening, CC can have profoundly negatively affects on quality of ... Read more...

Drug-induced fibrotic valvular heart disease.

13 Aug 2009 The initial association between the development of valvular heart disease and drugs stems from observations made during the use of methysergide and ergotamine for migraine prophylaxis in the 1960s. Since then, the appetite suppressants fenfluramine ... Read more...

Psychotherapy for obsessive-compulsive disorder.

30 Jul 2009 Cognitive-behavioral therapy (CBT) with exposure and response prevention is a first-line intervention for adult and childhood obsessive-compulsive disorder. Methodologically rigorous controlled trials have suggested that benefits from CBT exceed ... Read more...

Latest indexed articles for 'Serotonin Agents'

These are the very latest articles for this heading:

• Emerging drugs for chronic constipation. 30 Aug 2009
• Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. 30 Aug 2009
• Acute hippocampal sclerosis following ecstasy ingestion. 16 Aug 2009
• Drug-induced fibrotic valvular heart disease. 13 Aug 2009
• Psychotherapy for obsessive-compulsive disorder. 30 Jul 2009
• Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes? 26 Jul 2009
• Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. 17 Jul 2009
• Serotonin and Parkinson's disease: On movement, mood, and madness. 13 Jul 2009
• Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation. 29 Jun 2009
• The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats. 29 Jun 2009
• Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. 17 Jun 2009
• Triptans and troponin: a case report. 16 Jun 2009
• In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease. Jun 2009
• Serotonin receptor agonist quipazine promotes proliferation and apoptosis of human hepatocyte strain of L-02 strain. 30 May 2009
• Pharmacotherapy for the obese patient. 30 May 2009
• Inhibition of the bradycardic component of the von Bezold-Jarisch reflex and carotid chemoreceptor reflex by periaqueductal gray stimulation: involvement of medullary receptors. 7 May 2009
• Localization of diacylglycerol kinase epsilon on stress fibers in vascular smooth muscle cells. 5 May 2009
• Response disengagement on a spatial self-ordered sequencing task: effects of regionally selective excitotoxic lesions and serotonin depletion within the prefrontal cortex. 4 May 2009
• [Plasma membrane depolarization and activation of receptors for endogenous vasoconstrictors as possible mechanisms of potentiation of vasoconstrictive response to serotonin in traumatic shock in rats] 29 Apr 2009
• Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. 19 Apr 2009

See a longer list of these articles.

Technical information about 'Serotonin Agents'

Definition: Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.

Registry Number: 0

Descriptor UI: D018490

Alternative terms: Serotonin Agents; Agents, Serotonin; Serotonin Drugs; Drugs, Serotonin; Serotonergic Drugs; Drugs, Serotonergic; Serotonergic Agents; Agents, Serotonergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.850; D27.505.696.577.850;

History Note: 95; SEROTONIN NEURON AGENTS (NON MESH) was heading 1995

Technical Notes: GEN or unspecified; prefer specific groups or specific drugs